23andMe is low on cash and its stock is worth pennies. The CEO wants another chance | CNN Business
Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Main Street. Today, the company is struggling to remain listed on the Nasdaq.
You're viewing a single thread.
But she's asking nicely...